Declan Doogan's Net Worth
$119 Million
Who is Declan Doogan?
Declan Doogan has an estimated net worth of $119 Million. This is based on reported shares across multiple companies, which include Biohaven Pharmaceutical Holding Co Ltd., and TENAX THERAPEUTICS, INC..
SEC CIK
Declan Doogan's CIK is 0001704234
Past Insider Trading and Trends
2021 was Declan Doogan's most active year for acquiring shares with 10 total transactions. Declan Doogan's most active month to acquire stocks was the month of October. 2020 was Declan Doogan's most active year for disposing of shares, totalling 24 transactions. Declan Doogan's most active month to dispose stocks was the month of May. 2021 saw Declan Doogan paying a total of $4,398,760.00 for 3,647,246 shares, this is the most they've acquired in one year. In 2019 Declan Doogan cashed out on 320,000 shares for a total of $15,781,769.98, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Biohaven Pharmaceutical Holding Co Ltd. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4/A
| -2.34% | -41.31K |
$68.30 | -$2,829,151.54 | 1.73M |
Jun 15 - Jun 16
| |||
Form 4/A
| -2.49% | -50.95K |
$65.11 | -$3,321,622.88 | 2M |
Jun 11 - Jun 12
| |||
Form 4
| -2.74% | -24.52K |
$112.80 | -$2,766,432.98 | 870.65K |
Nov 29
| |||
Form 4
| +139.41% | 521.26K |
$62.26 | -$3,625.04 | 895.17K |
Nov 16
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 5
| |||
Form 4
| -18.28% | -140.00K |
$67.37 | -$9,431,750.04 | 626K |
Scheduled
|
Jun 15 - Jun 16
| ||
Form 4
| -17.28% | -160.00K |
$64.07 | -$10,251,052.54 | 766K |
Scheduled
|
Jun 11 - Jun 12
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 30
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 21
| |||
Form 4
| -8.75% | -88.83K |
$58.42 | -$5,189,444.00 | 926K |
Scheduled
|
Apr 12 - Apr 16
| ||
Form 4
| -1.09% | -11.18K |
$53.69 | -$599,999.94 | 1.01M |
Scheduled
|
Mar 22 - Mar 26
| ||
Form 4
| -6.73% | -101.02K |
$45.87 | -$4,672,921.84 | 1.4M |
Scheduled
|
Feb 27 - Mar 1
| ||
Form 4
| -4.87% | -76.90K |
$45.13 | -$3,452,588.08 | 1.5M |
Scheduled
|
Feb 22 - Feb 26
| ||
Form 4
| -0.19% | -2.08K |
$45.48 | -$94,508.76 | 1.11M |
Scheduled
|
Feb 15 - Feb 19
| ||
Form 4
| -3.46% | -40.00K |
$44.31 | -$1,772,307.36 | 1.12M |
Scheduled
|
Feb 12 - Feb 13
| ||
Form 4
| -3.34% | -40.00K |
$41.95 | -$1,678,000.00 | 1.16M |
Scheduled
|
Dec 3
| ||
Form 4
| -6.94% | -89.22K |
$35.25 | -$3,145,112.48 | 1.2M |
Scheduled
|
Jun 4 - Jun 5
| ||
Form 4
| -7.94% | -110.78K |
$35.03 | -$3,881,056.36 | 1.29M |
Scheduled
|
May 30 - Jun 1
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 1
| |||
Form 4
| -8.40% | -128.06K |
$26.95 | -$3,451,296.72 | 1.4M |
Scheduled
|
Jan 16 - Jan 18
| ||
Form 4
| -9.38% | -121.94K |
$26.78 | -$3,265,537.45 | 1.18M |
Scheduled
|
Jan 10 - Jan 12
| ||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
TENAX THERAPEUTICS, INC. (TENX) Snapshot price: $16.145
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
| 3.64M |
Aug 11
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 9
| |||
Form 4
| -18.50% | -567.87K |
—
|
—
| 2.5M |
Jun 30
| |||
Form 4
| +540.62% | 3.07M |
—
|
—
| 3.64M |
Jun 10 - Jun 11
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||